Gene polymorphism at position -308 of the tumor necrosis factor α promotor is not associated with disease progression in multiple sclerosis patients

Journal of Neurology

Volumn 246, Issue 10, 1999, Pages 949-954

  Maurer M ^a   Kruse, N ^a   Giess, R ^a   Kyriallis, K ^b   Toyka, K V ^a   Rieckmann, P ^a  

^a Chirurgischen Univ Klin P   (Germany)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Genetic polymorphism; Multiple sclerosis; Tumor necrosis factor

Indexed keywords

CYTOKINE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MESSENGER RNA SYNTHESIS; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; STROKE;

ALLELES; AMYOTROPHIC LATERAL SCLEROSIS; BASE SEQUENCE; CEREBROVASCULAR ACCIDENT; DISABILITY EVALUATION; DISEASE PROGRESSION; DNA; GENE FREQUENCY; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032739607     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050489     Document Type: Article

References (38)

1. Benveniste EN, Sparacio SM, Bethea JR (1989) Tumor necrosis factor enhances interferon gamma mediated class II antigens on mouse astrocytes. J Neuroimmunol 25:209-219
2. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P (1996) Gene polymorphism at position -308 of the tumor-necrosis-factor-α (TNF-α) in multiple sclerosis and its influence on the regulation of TNF-α production. Neurosci Lett 215:75-78
3. Cannella B, Raine CS (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37:424-435
4. Collier PM, Wojnarowska F, McGuire B, Welsh KI (1994) Polymorphism of tumor necrosis factor a promotor region of the MHC is strongly associated with linear IgA disease and affects prognosis. Br J Dermatol 131 [Suppl]: 22
5. Ebers GC, Sadovnick AD (1994) The role of genetic factors in multiple sclerosis suceptibility. J Neuroimmunol 54: 1-17
6. Ebers GC, Sadovnick AD, Risch NJ, the Canadian Collaborative Study Group (1995) A genetic basis for familial aggregation in multiple sclerosis. Nature 377:150-151
7. Ebers GC, Kukav K, Bulmann DE, Sadovnick AD, Rice G, Anderson C, Amstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O'Connor P, et al (1996) A full genome search in multiple sclerosis. Nat Genet 13:472-476
8. Epplen C, Dotzauer B, Jäckel S, Epplen JT, Przuntek H, Pöhlau D (1996) Multiple sclerosis (MS): relation of TNFα promotor and HLA-DRB1 polymorphisms with constitutive TNF secretion. Eur Cytokine Netw 7:255
9. Frei K, Eugster HP, Bopst M, Constantinescu CS, Lavi E, Fontana A (1997) Tumor necrosis factor a and lympo-toxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 185: 2177-2182
10. Fugger L, Morling N, Sandberg-Wolheim M, Ryder LP, Svejgaard A (1990) Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis. J Neuroimmunol 27:85-88
11. He B, Navikas V, Lundahl J, Soderstrom M, Hillert J (1995) Tumor necrosis factor a -308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol 63:143-147
12. Kruse N, Pette M, Toyka K, Rieckmann P (1997) Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J Immunol Methods 210:195-203
13. Kruse N, Mäurer M, Rieckmann P (1998) Determination of a genetic dimorphism within the human TNFa promotor using the 5′ nuclease essay. Eur Cytokine Netw 9:504
14. Kurtzke JF (1980) Epidemiological contributions to multiple sclerosis: an overview. Neurology 30:61-79
15. Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an Expanded Disability Rating Scale (EDSS). Neurology 13:144-1452
16. Lee LG, Connell CR, Bloch W (1993) Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 21:3761-3766
17. Liu J, Marino MW, Wong G, Grrail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CCA (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78-83
18. McGuire W, Hill AV, Allsopp CEM, Greenwood BM, Kwiatkowski D (1994) Variation in the TNFα promotor region associated with susceptibility to cerebral malaria. Nature 371: 508-510
19. Navikas V, Link H (1996) Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45:322-333
20. Olerup O, Hillert J (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38:1-15
21. Rieckmann P, Albrecht M, Kitze B, Weber F, Tumani H, Brooks A, Lüer W, Helwig A, Poser S (1995) Tumor necrosis factor α messenger RNA expression in patients with relapsing remitting multiple sclerosis associated with disease activity. Ann Neurol 37: 82-88
22. Rieckmann P, Bitsch A, the Multiple Sclerosis Study Group (1998) A double blind, placebo controlled, cross over trial of pentoxifylline in patients with relapsing remitting multiple sclerosis. J Neurol 245:386
23. Roth MP, Nogueira L, Coppin H, Clanet, Clyton J, Cambon-Thomsen A (1994) Tumor necrosis factor polymorphisms in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 51:93-99
24. Rudick RA, Ransohoff RM (1992) Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity. Arch Neurol 49:265-270
25. Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346
26. Selmaj K, Raine CS Canella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954
27. Sharief MK, Hentges R (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 325:467-472
28. Stuber F, Udalova IA, Book M, Drutskaya, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA (1996) - 308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promotor. J Inflamm 46:42-50
29. Van Oosten, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BME, Woody JN, Hartung HP, Polmann CH (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47: 1531-1534
30. Verjans GM, Messer G, Weiss EH, van der Linden SM, Kijlstra A (1992) Polymorphism of the tumor necrosis factor region in relation to disease. Rheum Dis Clin North Am 18:177-186
31. Weinshenker BG (1994) Natural history of multiple sclerosis. Ann Neurol 36 Suppl:S6-S11
32. Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS (1997) Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiole sclerosis. Neurology 49:378-385
33. Wilson AG, deVries N, Poicot F, Giovine FS, van der Putte LBA, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor α promotor region is strongly associated with HLA A1, B8, and DR 3 alleles. J Exp Med 177:557-560
34. Wilson AG, Clay FE, Crane AM, Cork MJ, Duff GW (1995) Genetics of tumor necrosis factor alpha in dermatitis herpetiformis. J Invest Dermatol 104: 856-858
35. Wilson AG, DiGiovine FS, Duff GW (1995) Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic diseases. J Inflamm 45:1-12
36. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor α promotor on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
37. Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG (1997) A population-based case control study of the tumor necrosis factor alpha -308 polymorphism in multiple sclerosis. Neurology 49:626-628
38. Wu W, McClain KL (1997) DNA polymorphisms and mutation of the tumor necrosis factor-α (TNF-α) promotor in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 17: 631-635